|
US8153602B1
(en)
*
|
1991-11-19 |
2012-04-10 |
Isis Pharmaceuticals, Inc. |
Composition and methods for the pulmonary delivery of nucleic acids
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5646262A
(en)
|
1994-07-28 |
1997-07-08 |
Georgetown University |
Antisense oligonucleotides against hepatitis B viral replication
|
|
US5994315A
(en)
*
|
1995-06-07 |
1999-11-30 |
East Carolina University |
Low adenosine agent, composition, kit and method for treatment of airway disease
|
|
US6825174B2
(en)
|
1995-06-07 |
2004-11-30 |
East Carolina University |
Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
|
|
US7034007B1
(en)
|
1995-06-07 |
2006-04-25 |
East Carolina University |
Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depletion
|
|
US6025339A
(en)
*
|
1995-06-07 |
2000-02-15 |
East Carolina University |
Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
|
|
KR20010030622A
(ko)
*
|
1997-09-17 |
2001-04-16 |
리차드 알. 이킨 |
다중 표적 하이브리드형성 핵산과 그들의 제조, 구성,제제, 키트 및 응용
|
|
JP2002514397A
(ja)
*
|
1998-05-14 |
2002-05-21 |
コーリー ファーマシューティカル ゲーエムベーハー |
ＣｐＧオリゴヌクレオチドを用いる造血調節の方法
|
|
AU4675699A
(en)
*
|
1998-06-08 |
1999-12-30 |
Epigenesis Pharmaceuticals, Inc. |
Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
|
|
US6210892B1
(en)
*
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
CN1330513A
(zh)
*
|
1999-04-06 |
2002-01-09 |
东卡罗来纳大学 |
低腺苷反义寡核苷酸、组合物、试剂盒及与支气管紧缩、肺炎、过敏及表面活性剂缺失相关的通气途径疾病的治疗方法
|
|
US7585847B2
(en)
*
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
CA2400573A1
(en)
*
|
2000-03-28 |
2001-10-04 |
Isis Pharmaceuticals Inc. |
Alteration of cellular behavior by antisense modulation of mrna processing
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
CA2425779C
(en)
|
2000-10-12 |
2013-08-06 |
University Of Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
CA2453362A1
(en)
*
|
2001-07-10 |
2003-01-23 |
Oligos Etc. Inc. |
Oligonucleotide-containing pharmacological compositions and their use
|
|
US7811992B2
(en)
|
2002-02-06 |
2010-10-12 |
Stasys Technologies, Inc. |
Anti-infarction molecules
|
|
AU2003253580A1
(en)
*
|
2002-02-26 |
2003-11-17 |
University Of Minnesota |
Variants of nedd4l associated with hypertension and viral budding
|
|
WO2004013160A2
(en)
|
2002-08-05 |
2004-02-12 |
University Of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
|
AU2003300919A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Coley Pharmaceutical Gmbh |
5' cpg nucleic acids and methods of use
|
|
AU2004226605A1
(en)
*
|
2003-04-02 |
2004-10-14 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
TWI235440B
(en)
*
|
2004-03-31 |
2005-07-01 |
Advanced Semiconductor Eng |
Method for making leadless semiconductor package
|
|
CA2564868C
(en)
*
|
2004-04-28 |
2013-11-26 |
Molecules For Health, Inc. |
Methods for treating or preventing restenosis and other vascular proliferative disorders
|
|
US7968762B2
(en)
*
|
2004-07-13 |
2011-06-28 |
Van Andel Research Institute |
Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
|
|
SG10201912554TA
(en)
|
2005-03-23 |
2020-02-27 |
Genmab As |
Antibodies against cd38 for treatment of multiple myeloma
|
|
US7476733B2
(en)
*
|
2005-03-25 |
2009-01-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease
|
|
CN101193646A
(zh)
*
|
2005-04-08 |
2008-06-04 |
科勒制药集团公司 |
治疗传染病加剧性哮喘的方法
|
|
US8080534B2
(en)
*
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
CA2625891A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Carlton D. Donald |
Inhibition of pax2 by defb1 induction as a therapy for cancer
|
|
WO2008036406A2
(en)
|
2006-09-21 |
2008-03-27 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic distrophy
|
|
EP2104516B1
(en)
|
2006-11-01 |
2015-01-07 |
University of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
|
JP2010512327A
(ja)
*
|
2006-12-11 |
2010-04-22 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
病的血管形成および脈管透過性の処置用の組成物および方法
|
|
US9526707B2
(en)
*
|
2007-08-13 |
2016-12-27 |
Howard L. Elford |
Methods for treating or preventing neuroinflammation or autoimmune diseases
|
|
CA2697957A1
(en)
|
2007-08-28 |
2009-03-12 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
WO2009032693A2
(en)
|
2007-08-28 |
2009-03-12 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
EP2268664B1
(en)
*
|
2007-12-03 |
2017-05-24 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Doc1 compositions and methods for treating cancer
|
|
US8202848B2
(en)
*
|
2008-03-17 |
2012-06-19 |
Board Of Regents, The University Of Texas System |
Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration
|
|
US20110262395A1
(en)
|
2008-05-08 |
2011-10-27 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
WO2010019963A2
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
US9289475B2
(en)
|
2008-11-06 |
2016-03-22 |
The Johns Hopkins University |
Treatment of chronic inflammatory respiratory disorders
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
WO2011031974A1
(en)
|
2009-09-10 |
2011-03-17 |
Southern Research Institute |
Acridine analogs in the treatment of gliomas
|
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
|
EP2580243B1
(en)
|
2010-06-09 |
2019-10-16 |
Genmab A/S |
Antibodies against human cd38
|
|
JP5598510B2
(ja)
|
2012-08-28 |
2014-10-01 |
トヨタ自動車株式会社 |
内燃機関
|
|
WO2014093688A1
(en)
|
2012-12-12 |
2014-06-19 |
1Massachusetts Institute Of Technology |
Compositions and methods for functional nucleic acid delivery
|
|
EP3071590A4
(en)
|
2013-11-21 |
2017-07-19 |
SeNA Research, Inc. |
Methods for structural determination of selenium derivatized nucleic acid complexes
|
|
WO2016018665A1
(en)
|
2014-07-31 |
2016-02-04 |
Uab Research Foundation |
Apoe mimetic peptides and higher potency to clear plasma cholesterol
|
|
KR102661616B1
(ko)
|
2016-07-28 |
2024-04-30 |
리제너론 파마슈티칼스 인코포레이티드 |
Gpr156 변이체 및 이들의 용도
|
|
CA3032320A1
(en)
|
2016-08-03 |
2018-02-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Tlr9 targeted therapeutics
|
|
RU2019126483A
(ru)
|
2017-01-23 |
2021-02-24 |
Ридженерон Фармасьютикалз, Инк. |
Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение
|
|
CN110997906B
(zh)
|
2017-06-05 |
2024-05-07 |
雷杰纳荣制药公司 |
B4galt1变体及其用途
|
|
CA3074652A1
(en)
|
2017-09-06 |
2019-03-14 |
Regeneron Pharmaceuticals, Inc. |
Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof
|
|
JP2020536500A
(ja)
|
2017-09-07 |
2020-12-17 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
溶質キャリアファミリー１４メンバー１（ｓｌｃ１４ａ１）の変異型及びその使用
|
|
US12016314B2
(en)
|
2017-09-08 |
2024-06-25 |
Ohio State Innovation Foundation |
MicroRNA inhibitor therapy in systemic lupus erythematosus
|
|
KR102694809B1
(ko)
|
2017-10-11 |
2024-08-16 |
리제너론 파마슈티칼스 인코포레이티드 |
Pnpla3 i148m 변이를 발현하는 환자의 간 질환의 치료에서의 hsd17b13의 저해
|
|
US11098363B2
(en)
|
2017-10-16 |
2021-08-24 |
Regeneron Pharmaceuticals, Inc. |
Cornulin (CRNN) variants and uses thereof
|
|
MA56457A
(fr)
|
2019-07-02 |
2022-05-11 |
Regeneron Pharma |
Modulateurs de hsd17b13 et leurs procédés d'utilisation
|
|
WO2024173343A1
(en)
|
2023-02-14 |
2024-08-22 |
Regeneron Pharmaceuticals, Inc. |
Compounds targeting hydroxysteroid 17-beta dehydrogenase (hsd17b) and uses thereof
|